Then, this study inspected published clinical cases with immunodeficiencies and found that 51.6% and 28.86% of patients with RAG1 and RAG2 mutations, correspondingly, had CpG methylation-mediated mutagenesis (p-value=0.0002). This evidence concerns the gene RAG2 and immune system disorder.